Immunocore Holdings (IMCR) Gross Profit (2021 - 2026)
Immunocore Holdings' Gross Profit was $114.84 million in Q2 2026, up 18.5% from $96.92 million a year earlier and up 8.1% from the prior quarter.
Powered by 
Analysis
Immunocore Holdings (IMCR) Gross Profit (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immunocore Holdings' Gross Profit was $426.04 million through Jun 30, 2026, up 20.5% year-over-year; for FY2025, it came in at $394.93 million, up 28.4% from FY2024.
- Gross Profit has now increased for four consecutive years, with a five-year compound annual growth rate of 58.3% (FY2020 to FY2025).
- In earlier years, Gross Profit was $307.47 million in FY2024 (+23.8%), $248.39 million in FY2023 (+47.8%), $168.06 million in FY2022 (+360.6%) and $36.49 million in FY2021 (-8.2%).
- The Q2 2026 figure marks the highest quarterly Gross Profit in data going back to Q3 2021.
- Compared with a year earlier, Gross Profit has increased for 13 straight quarters, with growth averaging 23.8% over the last eight quarters.
- Over the past five years, the year-over-year growth in Gross Profit ranged from 14.2% (Q1 2026) to 532.9% (Q4 2022).
- Per Business Quant data, IMCR's Gross Profit in the three quarters before Q2 2026 was $106.24 million (Q1 2026), $101.78 million (Q4 2025) and $103.18 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Immunocore Holdings | 1.56 Bn | -1.92 Bn | 114.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 114.84 Mn |
| Mar 31, 2026 | 106.24 Mn |
| Dec 31, 2025 | 101.78 Mn |
| Sep 30, 2025 | 103.18 Mn |
| Jun 30, 2025 | 96.92 Mn |
| Mar 31, 2025 | 93.05 Mn |
| Dec 31, 2024 | 83.72 Mn |
| Sep 30, 2024 | 79.80 Mn |
| Jun 30, 2024 | 73.69 Mn |
| Mar 31, 2024 | 70.26 Mn |
| Dec 31, 2023 | 69.96 Mn |
| Sep 30, 2023 | 64.57 Mn |
| Jun 30, 2023 | 58.66 Mn |
| Mar 31, 2023 | 54.44 Mn |
| Dec 31, 2022 | 56.25 Mn |
| Sep 30, 2022 | 48.48 Mn |
| Jun 30, 2022 | 39.99 Mn |
| Dec 31, 2021 | 8.89 Mn |
| Sep 30, 2021 | 8.17 Mn |
API Access
Immunocore Holdings Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=IMCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "IMCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=IMCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();